- Trials with a EudraCT protocol (4)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
4 result(s) found for: Bioanalysis.
Displaying page 1 of 1.
EudraCT Number: 2012-002183-27 | Sponsor Protocol Number: T-019 | Start Date*: 2013-04-03 | |||||||||||
Sponsor Name:Hammersmith Medicines Research | |||||||||||||
Full Title: Can netazepide eradicate the inflammatory response of the gastric mucosa to H. pylori infection? | |||||||||||||
Medical condition: Gastritis associated with H. pylori infection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-018102-22 | Sponsor Protocol Number: V00400SB102 | Start Date*: 2010-03-26 | |||||||||||
Sponsor Name:PIERRE FABRE DERMATOLOGIE | |||||||||||||
Full Title: A multicentre, open-label, repeated-dose, pharmacokinetic study of Propranolol in infants treated for proliferating infantile hemangiomas (IHs) requiring systemic therapy. | |||||||||||||
Medical condition: Proliferating Infantile Hemangioma | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-000174-29 | Sponsor Protocol Number: CNS7056-022 | Start Date*: 2018-07-25 | ||||||||||||||||
Sponsor Name:PAION UK Limited | ||||||||||||||||||
Full Title: Phase III confirmatory efficacy and safety trial of remimazolam (CNS7056) compared with propofol for intravenous anaesthesia during elective surgery | ||||||||||||||||||
Medical condition: Induction and maintenance of general anaesthesia (GA) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Prematurely Ended) BE (Completed) GB (Prematurely Ended) NL (Prematurely Ended) FR (Completed) IT (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2014-002418-22 | Sponsor Protocol Number: T-016 | Start Date*: 2014-11-07 | ||||||||||||||||||||||||||
Sponsor Name:Trio Medicines Ltd | ||||||||||||||||||||||||||||
Full Title: Randomized, placebo-controlled trial of YF476, a gastrin receptor antagonist, in Barrett’s esophagus (10-505; T-016) | ||||||||||||||||||||||||||||
Medical condition: Barrett's oesophagus | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: GB (Completed) | ||||||||||||||||||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
• EEA CTAs: Date study was authorised to proceed
• Outside EU/EEA: Date study was submitted in EudraCT
• Outside EU/EEA: Date study was submitted in EudraCT
